Get the Stockscreener App
3.4307
1.31%
-0.0093
Acurx Pharmaceuticals Inc stock is traded at $3.4307, with a volume of 7,349.
It is down -1.31% in the last 24 hours and down -34.08% over the past month.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.
See More
Previous Close:
$3.44
Open:
$3.42
24h Volume:
7,349
Relative Volume:
0.02
Market Cap:
$7.08M
Revenue:
-
Net Income/Loss:
$-14.58M
P/E Ratio:
-2.9832
EPS:
-1.15
Net Cash Flow:
$-9.80M
1W Performance:
-12.50%
1M Performance:
-34.08%
6M Performance:
-51.14%
1Y Performance:
-78.02%
1-Day Range:
$3.35
$3.42
1-Week Range:
$3.1713
$3.94
52-Week Range:
$3.1713
$25.00
Acurx Pharmaceuticals Inc Stock (ACXP) Company Profile
Name
Acurx Pharmaceuticals Inc
Sector
Industry
Phone
917-533-1469
Address
259 LIBERTY AVENUE, STATEN ISLAND
Compare ACXP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ACXP
Acurx Pharmaceuticals Inc
|
3.395 | 7.26M | 0 | -14.58M | -9.80M | -1.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.20 | 116.04B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
730.81 | 75.97B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
467.51 | 61.48B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
913.71 | 56.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.82 | 43.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Acurx Pharmaceuticals Inc Stock (ACXP) Latest News
Will Acurx Pharmaceuticals Inc. (3ZO) stock beat growth indexes2025 Volatility Report & Real-Time Market Trend Scan - Newser
Will Acurx Pharmaceuticals Inc. (3ZO) stock draw ESG focused fundsWeekly Trend Summary & AI Based Trade Execution Alerts - Newser
Will Acurx Pharmaceuticals Inc. (3ZO) stock justify high valuation2025 Stock Rankings & Weekly Breakout Stock Alerts - Newser
Is Acurx Pharmaceuticals Inc. stock a defensive play in 2025Entry Point & Verified Short-Term Plans - Newser
Will Acurx Pharmaceuticals Inc. (3ZO) stock beat Nasdaq index returns - Newser
Is Acurx Pharmaceuticals Inc. stock positioned for long term growthShort Setup & High Accuracy Trade Alerts - BỘ NỘI VỤ
Perhaps timely catching Acurx Pharmaceuticals Inc (ACXP) would be a good idea - Setenews
Why Acurx Pharmaceuticals Inc. (3ZO) stock could break out in 2025July 2025 Selloffs & Reliable Momentum Entry Alerts - BỘ NỘI VỤ
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Resigns with New to The Street for Long-Form Interviews, National TV Commercials, Earned Media, and Accredited Investor Events - Daytona Beach News-Journal
Wall Street Zen Upgrades Acurx Pharmaceuticals (NASDAQ:ACXP) to Hold - Defense World
Acurx Pharmaceuticals Inc. (ACXP) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Why Acurx Pharmaceuticals Inc. (3ZO) stock is upgraded to buy2025 Bull vs Bear & Free Long-Term Investment Growth Plans - newser.com
Is Acurx Pharmaceuticals Inc. (3ZO) stock a defensive play amid uncertaintyInsider Buying & Weekly Market Pulse Alerts - newser.com
Will Acurx Pharmaceuticals Inc. stock benefit from green energy trendsPortfolio Gains Report & Step-by-Step Trade Execution Guides - newser.com
Can Acurx Pharmaceuticals Inc. (3ZO) stock withstand sector downturnsJuly 2025 Fed Impact & Daily Growth Stock Tips - newser.com
What is the fair value of Acurx Pharmaceuticals Inc. stock nowTrade Exit Summary & Long Hold Capital Preservation Tips - newser.com
Is Acurx Pharmaceuticals Inc. stock resilient to inflationTrade Volume Report & High Conviction Buy Zone Picks - newser.com
Is Acurx Pharmaceuticals Inc. (3ZO) stock positioned for digital growth eraEarnings Risk Summary & Safe Entry Zone Tips - newser.com
Why Acurx Pharmaceuticals Inc. (3ZO) stock could be next leaderJuly 2025 Macro Moves & Entry and Exit Point Strategies - newser.com
Quantitative breakdown of Acurx Pharmaceuticals Inc. recent moveTrade Risk Assessment & Precise Entry and Exit Recommendations - newser.com
Is this a good reentry point in Acurx Pharmaceuticals Inc.July 2025 Snapshot & Advanced Swing Trade Entry Plans - newser.com
How to interpret RSI for Acurx Pharmaceuticals Inc. stockJuly 2025 Sentiment & Fast Gain Swing Trade Alerts - newser.com
Can Acurx Pharmaceuticals Inc. stock maintain operating margins2025 Biggest Moves & Verified Entry Point Signals - newser.com
Pattern recognition hints at Acurx Pharmaceuticals Inc. upsideLayoff News & Scalable Portfolio Growth Methods - newser.com
Acurx Pharmaceuticals Inc Stock (ACXP) Financials Data
Revenue
Net Income
Cash Flow
EPS
Acurx Pharmaceuticals Inc Stock (ACXP) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Sailer Carl | Director |
Jan 06 '25 |
Buy |
1.01 |
24,631 |
25,000 |
137,183 |
| LUCI DAVID P | President and CEO |
Jan 06 '25 |
Buy |
1.01 |
49,261 |
50,000 |
1,097,458 |
| Donohue James J. | Director |
Jan 06 '25 |
Buy |
1.01 |
9,852 |
10,000 |
22,352 |
| DELUCCIA ROBERT J | Director |
Jan 06 '25 |
Buy |
1.01 |
49,261 |
50,000 |
1,010,196 |
| DEAN JACK H | Director |
Jan 06 '25 |
Buy |
1.01 |
9,852 |
10,000 |
21,776 |
0.46%
1.57%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):